Cloning and functional characterization of inwardly rectifying K^+ channels expressed in pancreatic beta-cells
Cloning and functional characterization of inwardly rectifying K^+ channels expressed in pancreatic beta-cells
批准号:
07671107
负责人:
INAGAKI Nobuya
金额:
$1.6万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
在胰岛β细胞中,ATP敏感性钾通道(K_<;ATP>;通道)是调节葡萄糖诱导的胰岛素分泌的关键,也是口服降糖药磺脲类药物的靶点,该药广泛用于治疗非胰岛素依赖型糖尿病(NIDDM),但K_<;ATP>;通道的分子基础尚不清楚。最近,一个高亲和力的磺脲类受体(SUR1)被分离出来,它是三磷酸腺苷结合盒(ABC)超家族中的一员,但它不能引起钾通道电流。我们已经克隆了内向整流性K^+通道家族成员UK_<;ATP>;-1(Kir6.1),它在包括胰岛在内的多种组织中表达,但在克隆性β细胞系中不表达。随后,我们还克隆了BIR(Kir6.2),它与Kir6.1属于同一个亚家族,主要在胰岛和克隆性β细胞系中表达。我们已经证明了由SUR1和Kir6.2重组的K_<;ATP>;通道的性质与天然胰腺β细胞的特性相同,表明胰腺β细胞K_<;ATP>;通道是由Kir6.2和SUR1组成的复合体。我们还分离到了一个新的磺脲受体(SUR2),它与SUR1有68%的氨基酸同源性。SUR2基因在心肌和骨骼肌中含量丰富。SUR2和Kir6.2在COS1细胞中的共表达重组了天然心肌和骨骼肌中存在的K<;ATP>;通道,表明K<;ATP>;通道的药理性质是由磺脲类受体亚基家族决定的。我们还测定了人Kir6.2基因的结构和染色体定位,发现人的SUR1和Kir6.2基因聚集在染色体11p15.1上。我们已经在Kir6.2基因和与Kir6.2基因相近的微卫星DNA中发现了几个多态性,并表明Kir6.2基因的遗传变异在日本人和高加索人NIDDM的易感性中不起主要作用。
英文摘要
In pancreatic beta-cells, ATP-sensitive potassium channels (K_<ATP> channels) are crucial for the regulation of glucoseinduced insulin secretion and are the target for the sulfonylureas, oral hypoglycemic agents widely used in the treatment of non-insulin-dependent diabetes mellitus (NIDDM), but the molecular basis of the K_<ATP> channels was unknown. Recently, a high affinity receptor for sulfonylureas (SUR1), a member of the ATP-binding cassette (ABC) superfamily, has been isolated, but it did not elicit K_<ATP> channel currents. We have cloned a member of the inward rectifier K^+ channel family, uK_<ATP>-1 (Kir6.1), which is expressed in various tissues including pancreatic islets, but not in clonal beta-cell lines. Subsequently, we also have cloned BIR (Kir6.2), which belongs to the same subfamily as Kir6.1 and is expressed predominantly in pancreatic islets and clonal beta-cell lines. We have shown that the properties of the K_<ATP> channel reconstituted from SUR1 and Kir6.2 are those described for native pancreatic beta-cells, demonstrating that the pancreatic beta-cell K_<ATP> channel is a complex composed of Kir6.2 and SUR1. We also have isolated a novel sulfonylurea receptor (SUR2) which shares 68% amino acisd identity with SUR1. SUR2 mRNA is abundant in heart and skeletal muscle. Coexpression of SUR2 and Kir6.2 in COS1 cells reconstitutes K_<ATP> channels found in native cardiac and skeletal muscle, indicating that the pharmacological properties of K_<ATP> channels are determined by a family of sulfonylurea receptor subunits. We also have determined the structure and chromosomal localization of human Kir6.2 gene, and have shown that human SUR1 and Kir6.2 genes are clustered at chromosome 11p15.1. We have found several polymorphysms in the Kir6.2 gene and microsatellite DNA polymorphysms close to the Kir6.2 gene, and have shown that genetic variation in the Kir6.2 gene does not play a major role in susceptibility to NIDDM in Japanese and Caucasian.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Inagaki,N.et al.: "cDNA sequence,gene structure,and chromosomal localization of the human ATP-sensitive potassium channel,uKATP-1,Gene (KCNJ8)." Genomics. 30. 102-104 (1995)
Inagaki,N.et al.:“人类 ATP 敏感钾通道 uKATP-1 基因 (KCNJ8) 的 cDNA 序列、基因结构和染色体定位。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ihara, Y.et al.: "Molecular diversity and functional characterization of voltage-dependent calcium channels (CACN4) expressed in pancreatic beta-cells." Mol.Endocrinol.9. 121-130 (1995)
Ihara, Y. 等人:“胰腺 β 细胞中表达的电压依赖性钙通道 (CACN4) 的分子多样性和功能特征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
水田雅也 他: "分子糖尿病学の進歩-基礎から臨床まで-1995" 金原出版, 6 (1995)
Masaya Mizuta 等人:“分子糖尿病的进展 - 从基础知识到临床实践 - 1995” Kanehara Publishing,6 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ihara,Y.et al.: "Molecular diversity and functional characterization of voltage-dependent calcium channels (CACN4) expressed in pancreatic β-cells." Mol. Endocrinol.9. 121-130 (1995)
Ihara, Y. 等人:“胰腺 β 细胞中表达的电压依赖性钙通道 (CACN4) 的分子多样性和功能特征。”121-130 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Wang,C-Z.et al.: "Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues." Biochem. Biophys. Res. Commun.220. 196-202 (1996)
Wang,C-Z.等人:“第四种 P2X 受体亚型的克隆和药理学特征,该亚型广泛表达于大脑和外周组织,包括各种内分泌组织。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Development of a noninvasive method for beta cell mass measurement using a nuclear magnetic resonance
-
批准号:25670258
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:INAGAKI Nobuya
-
依托单位:
Development of the novel diagnostic method for quantification ofpancreatic beta-cell mass by magnetic resonance imaging
-
批准号:22390185
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:INAGAKI Nobuya
-
依托单位:
Molecular Basis of Novel Membrane Transport Mechanism
-
批准号:15GS0301
-
项目类别:Grant-in-Aid for Creative Scientific Research
-
资助金额:$309.17万
-
财政年份:2003
-
负责人:INAGAKI Nobuya
-
依托单位:
Structure and physiological role of ATP-sensitive potassium channel
-
批准号:11470009
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:1999
-
负责人:INAGAKI Nobuya
-
依托单位:
Development of drugs which open or close ATP-sensitive KィイD1+ィエD1channels
-
批准号:10557002
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.1万
-
财政年份:1998
-
负责人:INAGAKI Nobuya
-
依托单位:
Elucidation of the mechanisms underlying the regulation of ATP-sensitive K^+ channels by sulfonylureas
-
批准号:09671025
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:INAGAKI Nobuya
-
依托单位:
海外基金